# AVANOS MEDICAL, INC. (AVNS) — merger/definitive [completed]
Source: SEC API (secapi.ai) · situation sit_dc748ecd6738ac1ad8fc · retrieved 2026-08-11T16:01:36.017Z

## Overview
Avanos Medical, Inc. is an orthopedic, prosthetic and surgical appliances and supplies company.

On July 27, 2026, Avanos Medical, Inc. completed its merger with A-AV MergerSub, Inc., a subsidiary of A-AV Holdco I, Inc., which is affiliated with American Industrial Partners. Each outstanding share of Avanos common stock was converted into the right to receive $25.00 per share in cash. The aggregate merger consideration paid to company stockholders was approximately $1,200 million. The transaction was funded through equity contributions to Parent and debt financing under a new Credit Agreement providing for $675.0 million in initial term loans, $100.0 million in delayed draw term loan commitments, and a $100.0 million priority revolving credit facility. Following the merger, Avanos became a wholly-owned subsidiary of Parent, and its common stock was delisted from the New York Stock Exchange.

## Terms
- Counterparty: A-AV Holdco I, Inc. (affiliated with American Industrial Partners) · Deal value: $1.20B · Consideration: cash · Stake: 100% · Price/share: $25

## Key dates
- Announced 2026-07-22 · Record 2026-06-18 · Vote 2026-07-22 · Expected close 2026-07-27 · Completed 2026-07-27

## Timeline
- 2026-07-22 · 8-K (0001606498-26-000096): 8-K - AVANOS MEDICAL, INC. — *Avanos Medical, Inc. is a medical technology company focused on delivering clinically superior medical device solutions, including nutrition delivery systems and opioid-reduction solutions, with leading market positions across its portfolio.* On July 22, 2026, Avanos Medical, Inc. stockholders voted to approve the pending acquisition by affiliates of investment funds advised by American Industrial Partners (AIP). Approximately 99.75% of shares voted at the special meeting were cast in favor of the transaction, representing approximately 74.96% of total outstanding shares as of the June 18, 2026 record date. Under the merger agreement dated April 13, 2026, Avanos stockholders will receive $25.00 per share in cash at the effective time of the acquisition. All required regulatory approvals have been received, and the transaction is expected to close no later than July 27, 2026, subject to customary closing conditions.
  https://www.sec.gov/Archives/edgar/data/1606498/0001606498-26-000096.txt
- 2026-07-30 · 8-K (0001606498-26-000115): 8-K - AVANOS MEDICAL, INC. — *Avanos Medical, Inc. is an orthopedic, prosthetic and surgical appliances and supplies company.* On July 27, 2026, Avanos Medical, Inc. completed its merger with A-AV MergerSub, Inc., a subsidiary of A-AV Holdco I, Inc., which is affiliated with American Industrial Partners. Each outstanding share of Avanos common stock was converted into the right to receive $25.00 per share in cash. The aggregate merger consideration paid to company stockholders was approximately $1,200 million. The transaction was funded through equity contributions to Parent and debt financing under a new Credit Agreement providing for $675.0 million in initial term loans, $100.0 million in delayed draw term loan commitments, and a $100.0 million priority revolving credit facility. Following the merger, Avanos became a wholly-owned subsidiary of Parent, and its common stock was delisted from the New York Stock Exchange.
  https://www.sec.gov/Archives/edgar/data/1606498/0001606498-26-000115.txt

## Citations
- 0001606498-26-000096 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000160649826000096
- 0001606498-26-000115 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000160649826000115